Skip to main content
SpringerLink
Log in

Long-term treatment outcomes of coretherm microwave feedback thermotherapy

  • Published:
Current Prostate Reports

Abstract

The gold standard for definitive management of symptomatic benign prostatic hypertrophy is transurethral resection of the prostate (TURP). Despite its efficacy, TURP has significant morbidity/mortality concerns such as hemorrhage and transurethral resection syndrome. This is especially worrisome for the medically high-risk patient, but the high rates of retrograde ejaculation found with TURP also pose a problem for young patients. A minimally invasive, outpatient alternative to TURP that has long-term efficacy, low morbidity/mortality, and provides a cost-effective advantage is in high demand. This review article discusses microwave thermotherapy as such an option and reports the long-term experience with the CoreTherm (CoreTherm Operations AB, Sweden) device.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Guess HA, Arrighi HM, Metter EJ, Fozard JL: Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990, 17:214–246.

    Article  Google Scholar 

  2. Verhamme KM, Dieleman JP, Bleumink GS, et al.: Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care: The Triumph project. Eur Urol 2002, 42:323–328.

    Article  PubMed  CAS  Google Scholar 

  3. Laguna MP, Muschter R, Debruyne FM: Microwave thermotherapy: historical overview. J Endourol 2000, 17:603–609.

    Article  Google Scholar 

  4. Edwards LE: History of non-surgical treatment. In Benign Prostatic Hypertrophy. Edited by Hinman F Jr. New York: Springer-Verlag; 1983:30.

    Chapter  Google Scholar 

  5. de la Rosette J, Laguna P, Gravas S, et al.: Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia? J Endourol 2003, 17:245–251.

    Article  PubMed  Google Scholar 

  6. McCaskey D: Quartz light therapy in obstinate prostatic affections. NY Med J 1921, 113:647–648.

    Google Scholar 

  7. Yerushalmi A, Servadio C, Leib Z, et al.: Local hyperthermia for the treatment of carcinoma of the prostate: a preliminary report. Prostate 1982, 3:623–630.

    Article  PubMed  CAS  Google Scholar 

  8. Yerushalmi A, Fishelovitz, Singer D, et al.: Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 1985, 133:873–876.

    PubMed  CAS  Google Scholar 

  9. Devonec M, Ogden C, Perrin P, St Clair Carter S: Clinical response to transurethral microwave thermotherapy is thermal dose dependent. Eur Urol 1993, 23:267–274.

    PubMed  CAS  Google Scholar 

  10. Vujaskovic Z, McChesney Gillette S, Powers BE, et al.: Effects of intraoperative hyperthermia on canine sciatic nerve: histopathologic and morphometric studies. Int J Hyperthermia 1994, 10:845–855.

    Article  PubMed  CAS  Google Scholar 

  11. Mazo EB, Kudriavtsev IUV, Petukhov EB, et al.: [The mechanism of the action of local transrectal hyperthermia in treating prostatic adenoma]. Urol Nefrol (Mosk) 1994, 1:45–49.

    Google Scholar 

  12. Fabricius PG, Schafer J: Efficacy of transrectal hyperthermia for benign prostatic hyperplasia: a placebo-controlled study [Abstract 602]. J Urol 1991, 145:363A.

    Google Scholar 

  13. Zerbib M, Steg A, Conquy S, Debre B: Hyperthermia: a randomized prospective study applying hyperthermia or a sham procedure in obstructive benign hyperplasia of the prostate. Prog Clin Biol Res 1994, 386:439–448.

    PubMed  CAS  Google Scholar 

  14. Bolmsjo M, Schelin S, Wagrell L, et al.: Cell-kill modeling of microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol 2000, 14:627–635.

    Article  PubMed  CAS  Google Scholar 

  15. Brehmer M, Baba S: Transurethral microwave thermotherapy: How does it work? J Endourol 2000, 14:611–615.

    Article  PubMed  CAS  Google Scholar 

  16. Carter S, Tubaro A: Relation between intraprostatic temperature and clinical outcome in microwave thermotherapy. J Endourol 2000, 14:617–625.

    Article  PubMed  CAS  Google Scholar 

  17. Nordling J, Schelin S: Intraprostatic temperature measurement during microwave treatment provides online control of tissue necrosis volume using ProstaLund microwave feedback treatment [Abstract]. J Endourol 2001, 15(suppl):A89.

    Google Scholar 

  18. Perachino M, Bozzo W, Puppo P, et al.: Does transurethral thermo therapy induce a long-term alpha blockade? Eur Urol 1993, 23:299–301.

    PubMed  CAS  Google Scholar 

  19. Brehmer M, Hilliges M, Kinn AC: Denervation of the periurethral prostatic tissue by transurethral microwave thermotherapy. Scand J Urol Nephrol 2000, 34:42–45.

    Article  PubMed  CAS  Google Scholar 

  20. Hoffmann AL, de la Rosette JJ, Wijkstra H: Intraprostatic temperature monitoring during transurethral microwave thermotherapy: Status and future developments. J Endourol 2000, 14:637–642.

    Article  PubMed  CAS  Google Scholar 

  21. Bursa B, Wammack R, Djavan B, et al.: Outcome predictors of high-energy transurethral microwave thermotherapy. Tech Urol 2000, 6:262–266.

    PubMed  CAS  Google Scholar 

  22. Floratos DL, Aarnink RG: Predictors of treatment outcome for high-energy transurethral microwave thermotherapy. J Endourol 2000, 14:643–649.

    Article  PubMed  CAS  Google Scholar 

  23. d’Ancona FC, Francisca EA, Debruyne FM, de la Rosette JJ: Highenergy transurethral microwave thermotherapy in men with lower urinary tract symptoms. J Endourol 1997, 11:285–289.

    Article  PubMed  Google Scholar 

  24. d’Ancona FC, Francisca EA, Hendriks JC, et al.: How to select patients for high-energy transurethral microwave thermotherapy. Urology 1999, 53:111–117.

    Article  PubMed  Google Scholar 

  25. Schelin S: Mediating transurethral microwave thermotherapy by intraprostatic and periprostatic injections of mepivacaine epinephrine: effects on treatment time, energy consumption, and patient comfort. J Endourol 2002, 16:117–121.

    Article  PubMed  Google Scholar 

  26. Francisca EA, Keijzers GB, d’Ancona FC, et al.: Lower energy thermotherapy in the treatment of benign prostatic hypertrophy: long-term follow-up results of a multicenter international study. World J Urol 1999, 17:279–284.

    Article  PubMed  CAS  Google Scholar 

  27. Nawrocki JD, Bell TJ, Lawrence WT, Ward JP: A randomized, controlled trial of transurethral microwave thermotherapy. Br J Urol 1997, 79:389–393.

    Article  PubMed  CAS  Google Scholar 

  28. De Wildt MJ, Hubregtse M, Ogden C, et al.: A 12-month study of the placebo effect in transurethral microwave thermotherapy. Br J Urol 1996, 77:221–227.

    Article  PubMed  Google Scholar 

  29. d’Ancona FC, Francisca EA, Witjes WP, et al.: Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: longterm results. Br J Urol 1998, 81:259–264.

    Article  PubMed  Google Scholar 

  30. Floratos DL, Kiemeney LA, Rossi C, et al.: Long-term follow-up of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001, 165:1533–1538.

    Article  PubMed  CAS  Google Scholar 

  31. Thalmann GN, Mattei A, Treuthardt C, et al.: Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results. J Urol 2002, 167:2496–2501.

    Article  PubMed  Google Scholar 

  32. Gravas S, Laguna M, de la Rosette JJ: Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up. J Endourol 2003, 17:425–430.

    Article  PubMed  Google Scholar 

  33. Miller PD, Kastner C, Ramsey EW, Parsons K: Cooled thermotherapy for the treatment of benign prostatic hyperplasia: durability of results obtained with the Targis system. Urology 2003, 60:1160–1165.

    Article  Google Scholar 

  34. Djavan B, Roehrborn CG, Shariat S, et al.: Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. J Urol 1999, 161:139–143.

    Article  PubMed  CAS  Google Scholar 

  35. Wagrell L, Schelin S, Nordling J, et al.: Feedback microwave thermotherapy versus TURP for clinical BPH: a randomized controlled multicenter study. Urology 2002, 60:292–299. Noteworthy study of interest.

    Article  PubMed  Google Scholar 

  36. Osman Y, Wadie B, El-Diasty T, Larson T: High-energy transurethral microwave thermotherapy: symptomatic vs urodynamic success. BJU Int 2003, 91:365–370. Interesting study.

    Article  PubMed  CAS  Google Scholar 

  37. Lynch WJ, Graber SJ: Transurethral microwave thermotherapy: symptom relief vs urodynamic changes. J Endourol 2000, 14:657–660.

    Article  PubMed  CAS  Google Scholar 

  38. Rubeinstein JN, McVary KT: Transurethral microwave thermotherapy for benign prostatic hyperplasia. Int Braz J Urol 2003, 29:251–263. Noteworthy review.

    Article  PubMed  Google Scholar 

  39. Ramsey EW, Dahlstrand C: Durability of results obtained with transurethral microwave thermotherapy in the treatment of men with symptomatic benign prostate hyperplasia. J Endourol 2000, 14:671–675.

    Article  PubMed  CAS  Google Scholar 

  40. Francisca EA, d’Ancona FC, Meuleman EJ, et al.: Sexual function following high-energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999, 161:486–490.

    Article  PubMed  CAS  Google Scholar 

  41. Gravas S, Laguna MP, De La Rosette JJ: Application of external microwave thermotherapy in urology: past, present, future. J Endourol 2003, 17:659–666. Noteworthy review.

    Article  PubMed  Google Scholar 

  42. Devonec M, Dahlstrand C: Temporary urethral stenting after high-energy transurethral microwave thermotherapy of the prostate. World J Urol 1998, 16:120–123.

    Article  PubMed  CAS  Google Scholar 

  43. Manyak MJ, Ackerman SJ: Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy. J Endourol 2002, 16:51–56.

    Article  PubMed  Google Scholar 

  44. De la Rosette JJ, Floratos DL, Severens JL, et al.: Transurethral resection vs. microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2004, 92:713–718. Noteworthy study.

    Article  Google Scholar 

  45. Kobelt G, Spangberg A, Mattiasson A: The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia. BJU Int 2004, 93:543–548. Noteworthy study.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Long Island Jewish Medical Center, 270-05 76th Avenue, 11040, New Hyde Park, NY, USA

    Evan R. Eisenberg MD

Authors
  1. Evan R. Eisenberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gopal H. Badlani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenberg, E.R., Badlani, G.H. Long-term treatment outcomes of coretherm microwave feedback thermotherapy. Curr prostate rep 2, 179–186 (2004). https://doi.org/10.1007/s11918-004-0019-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11918-004-0019-4

Keywords

Search

Navigation